Papular mucinosis in chronic psoriatic erythroderma. Report of a case.
D000324:Adrenocorticotropic Hormone / Q000009:adverse effects*; D000328:Adult; D000963:Antimetabolites / Q000009:adverse effects*; D003033:Coal Tar / Q000627:therapeutic use; D003873:Dermatitis, Exfoliative / Q000150:complications / Q000188:drug therapy*; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D006854:Hydrocortisone / Q000009:adverse effects; D008297:Male; D015122:Mercaptopurine / Q000009:adverse effects; D008727:Methotrexate / Q000009:adverse effects; D009059:Mouth Diseases / Q000139:chemically induced; D009912:Oral Manifestations; D011239:Prednisolone / Q000009:adverse effects; D011565:Psoriasis / Q000188:drug therapy*; D018805:Sepsis / Q000139:chemically induced; D012871:Skin Diseases / Q000188:drug therapy / Q000209:etiology*; D014456:Ulcer / Q000139:chemically induced
D000963:Antimetabolites; D005938:Glucocorticoids; D003033:Coal Tar; D000324:Adrenocorticotropic Hormone; D011239:Prednisolone; D015122:Mercaptopurine; D006854:Hydrocortisone; D008727:Methotrexate